Atlas Trials

Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)

Clinical trial NCT03071965 · COMPLETED

Trial details

NCT number
NCT03071965
Sponsor
Neurotech Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
MacTel (Macular Telangiectasia) Type 2
Start date
2017-05-12
Primary completion
2021-05-11
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.